ST
STJ

Smithfield Trust’s St Jude Medical STJ Stock Holding History

Smithfield Trust’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-600
Closed -$48K – 838
2016
Q4 		$48K Hold
600
– – 0.01% 524
2016
Q3 		$48K Hold
600
– – 0.01% 517
2016
Q2 		$47K Hold
600
– – 0.01% 496
2016
Q1 		$33K Hold
600
– – 0.01% 549
2015
Q4 		$37K Sell
600
-468
-44% -$29.5K 0.01% 532
2015
Q3 		$67K Hold
1,068
– – 0.01% 443
2015
Q2 		$78K Hold
1,068
– – 0.02% 439
2015
Q1 		$70K Hold
1,068
– – 0.01% 473
2014
Q4 		$69K Hold
1,068
– – 0.01% 466
2014
Q3 		$64K Buy
1,068
+468
+78% +$30.6K 0.01% 484
2014
Q2 		$42K Hold
600
– – 0.01% 561
2014
Q1 		$39K Hold
600
– – 0.01% 564
2013
Q4 		$37K Hold
600
– – 0.01% 552
2013
Q3 		$32K Hold
600
– – 0.01% 544
2013
Q2 		$27K Buy
+600
New +$26K 0.01% 547

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Smithfield Trust's STJ Position: Q1 2017 in Review

Smithfield Trust sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 600 shares — an estimated $48K sold.

Smithfield Trust first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $78K in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Smithfield Trust reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Smithfield Trust sold 600 St Jude Medical shares in Q1 2017, an estimated $48K.
  • Smithfield Trust first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Smithfield Trust's St Jude Medical position peaked at $78K in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Smithfield Trust's 13F filing for Q1 2017, filed 1 May 2017.